ATX 11.9% 5.9¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-8

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    there’s no doubt it looks promising and a response rate of 6/14 (43%) is on the face of it better than the MPACT trial (23%) but I’m always cautious of making comparisons between two very uneven groups. This is n=14 vs n=430 in MPACT gem/abrax arm. 30 fold difference!
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
5.9¢
Change
-0.008(11.9%)
Mkt cap ! $15.48M
Open High Low Value Volume
6.5¢ 6.5¢ 5.6¢ $39.03K 647.7K

Buyers (Bids)

No. Vol. Price($)
1 50000 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
5.9¢ 36 1
View Market Depth
Last trade - 14.19pm 20/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.